Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, Sept 17, 2020. United States-based pharmaceutical company Eli Lilly will continue to pour research and development investments in China to accelerate local pharmaceutical innovations and benefit the patients, said a senior executive of the company. The company invests 25 percent of its revenue a …
